Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clélia Mathieu

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Cancer drug resistance: rationale for drug delivery systems and targeted inhibition of HSP90 family proteinsClélia Mathieu, Samir Messaoudi, Elias Fattal, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 3, 2026
Inhibition of TRAP1 in the C-terminal domain influences mitochondria properties and breast cancer cell metabolismClélia Mathieu, Jessica Ristow Branco, Patricia Zancan, et al.
Advanced Healthcare Materials|October 28, 2021
Anti-BCMA Immuno-NanoPET Radiotracers for Improved Detection of Multiple MyelomaEloise Thomas, Clélia Mathieu, Patricia Moreno-Gaona, et al.
International Journal of Nanomedicine|October 14, 2017
Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastomaEloïse Thomas, Ludovic Colombeau, Mickaël Gries, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2020
Anti-MUC1-C Antibody-Conjugated Nanoparticles Potentiate the Efficacy of Fractionated Radiation TherapyAlexandre Detappe, Clélia Mathieu, Caining Jin, et al.
Advanced Healthcare Materials|March 6, 2024
Supramolecular Heterodimer Peptides Assembly for Nanoparticles FunctionalizationClélia Mathieu, Shayamita Ghosh, Julien Draussin, et al.
Small (Weinheim an Der Bergstrasse, Germany)|January 1, 2023
Clinically Translatable Transcrocetin Delivery Platform for Correction of Tumor Hypoxia and Enhancement of Radiation Therapy EffectsMarie-Charlotte Diringer, Pierre Coliat, Clélia Mathieu, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 17, 2023
Subcutaneous Administration of a Zwitterionic Chitosan-Based Hydrogel for Controlled Spatiotemporal Release of Monoclonal AntibodiesThomas Gréa, Guillaume Jacquot, Arthur Durand, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Cancer drug resistance: rationale for drug delivery systems and targeted inhibition of HSP90 family proteinsClélia Mathieu, Samir Messaoudi, Elias Fattal, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 3, 2026
Inhibition of TRAP1 in the C-terminal domain influences mitochondria properties and breast cancer cell metabolismClélia Mathieu, Jessica Ristow Branco, Patricia Zancan, et al.
Advanced Healthcare Materials|October 28, 2021
Anti-BCMA Immuno-NanoPET Radiotracers for Improved Detection of Multiple MyelomaEloise Thomas, Clélia Mathieu, Patricia Moreno-Gaona, et al.
International Journal of Nanomedicine|October 14, 2017
Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastomaEloïse Thomas, Ludovic Colombeau, Mickaël Gries, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2020
Anti-MUC1-C Antibody-Conjugated Nanoparticles Potentiate the Efficacy of Fractionated Radiation TherapyAlexandre Detappe, Clélia Mathieu, Caining Jin, et al.
Advanced Healthcare Materials|March 6, 2024
Supramolecular Heterodimer Peptides Assembly for Nanoparticles FunctionalizationClélia Mathieu, Shayamita Ghosh, Julien Draussin, et al.
Small (Weinheim an Der Bergstrasse, Germany)|January 1, 2023
Clinically Translatable Transcrocetin Delivery Platform for Correction of Tumor Hypoxia and Enhancement of Radiation Therapy EffectsMarie-Charlotte Diringer, Pierre Coliat, Clélia Mathieu, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 17, 2023
Subcutaneous Administration of a Zwitterionic Chitosan-Based Hydrogel for Controlled Spatiotemporal Release of Monoclonal AntibodiesThomas Gréa, Guillaume Jacquot, Arthur Durand, et al.
Pageof 1